Form 6-K GLAXOSMITHKLINE PLC For: Jan 28
FORM 6-K/A
�
�
SECURITIES AND EXCHANGE COMMISSION(
Washington D.C. 20549
�
�
Report of Foreign Issuer
�
�
Pursuant to Rule 13a-16 or 15d-16 of(
athe Securities Exchange Act of 1934
�
�
�
For period ending�January 2015
�
GlaxoSmithKline plc
(Name of registrant)(
�
�
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)(
�
�
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F(
�
�
Form 20-F x��� �Form 40-F(
�
--(
�
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.(
�
�
Yes����� No x
--
�
�
GlaxoSmithKline plc (the "Company")
�
Director Declaration
�
In conformity with Listing Rule 9.6.14, the Company hereby notifies the market that Ms Lynn Elsenhans, a Non-Executive Director of the Company, was appointed as a Director to the Board of Flowserve Corporation on 8 September 2014.
�
�
V A Whyte
Company Secretary
�
28 January 2015
�
��
SIGNATURES
�
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.(
�
�
GlaxoSmithKline plc
(Registrant)(
Date:�January 28,�2015�
�
�
By:�VICTORIA WHYTE
----------------------
�
�
Victoria�Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Heineken Holding N.V. Annual General Meeting of Shareholders adopts all proposals
- InvestorNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Releases 2024 Production Report, Corporate Update
- InvestorNewsBreaks – Diamond Lake Minerals Inc. (DLMI), BOXABL Announce Partnership to Bring Affordable Housing to the Public, Digital Tokens to Investors
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!